
Today on Pharmaceutical Processing
Nymi, Caliber partner on passwordless authentication for pharma manufacturing
Nymi today announced a strategic partnership with Caliber Technologies to accelerate digital transformation in pharmaceutical manufacturing. The partnership aims to enable passwordless authentication on the shop floor. This reduces manual logins and streamlines electronic signatures. Nymi offers the Band biometric, wearable device that authenticates users via fingerprint and facilitates a secure, continuous identity across applications,…Hemco highlights its self-contained workstations
NEWS RELEASE: Hemco highlights its MicroFlow rust-resistant, self-contained workstations Independence, Missouri — Hemco is selling its MicroFlow self-contained workstations for any environment where people may be subject to small amounts of non-hazardous fumes and odors. MicroFlow is a ductless, carbon-filtered workstation equipped with activated carbon filtration. It is designed to collect small amounts of non-hazardous fumes…Sponsored Content See More >
Regulatory See More >

Putting patients first in clinical trials
Clinical trials offer clinicians a unique opportunity to lead advances in medicine, granting access to cutting-edge therapies that address unmet patient needs. They are a cornerstone of clinical practice that enhance patient outcomes, particularly for those with complex or refractory cases who have exhausted standard treatment options. Clinicians understandably prioritize the well-being and interests of…

Confidently navigate the transition from bench to batch

FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension

Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths

Eicos Sciences’ FDA-approved Aurlumyn promises to drastically reduce frostbite amputations
Learn how to rapidly develop smart and sustainable engineering and production processes See More >

Personalized medicine: advanced technology is saving lives
The concept of a “batch size one” in pharmaceutical manufacturing is closer than ever. There are companies advancing cell therapies in which body cells are used to heal or support the individual patient. These cells are manipulated or edited to change certain biological characteristics before being transferred to the patient. Personalized medicine is truly about…
Facility See More >

Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Great Point Partners has acquired a majority stake in Eutecma, a Germany-based developer of reusable and modular temperature-controlled packaging for pharmaceutical cold chain logistics. The investment will support Eutecma’s global expansion strategy, particularly in the U.S. market, and bolster its efforts to reduce emissions and waste in drug shipping and storage. Eutecma supplies passive cooling…
Supply Chain See More >

Sandoz breaks ground on biosimilar plant in Slovenia
Sandoz announced that it began construction on a new, state-of-the-art biosimilars production center in Brnik, Slovenia. The $440 million project enables sterile product manufacturing in the region. It brings the company’s total planned and ongoing investment in Slovenia to more than $1.1 billion by 2029. Sandoz already has ongoing investments there, including a new biosimilar…
Recalls See More >

Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
Japanese health authorities searched a Kobayashi Pharmaceutical factory in Japan following reports of five deaths related to dietary supplements, Reuters reports. The plant inspection in western Japan is the second in recent days as health authorities inspected the company’s Osaka facility. In addition to the five reported deaths, there have been more than 100 hospitalizations…